NeuroInDx

NeuroInDx completes NIH SBIR Commercialization Assistance Program

lili — Thu, 30 Jun 2011 01:09:59 +0000

NeuroInDx completes NIH SBIR Commercialization Assistance Program by the Larta Insitute.

lili — Wed, 22 Jun 2011 01:22:16 +0000

NeuroInDx presents its CTAS project at the 13th Annual NIH SBIR/STTR Conference in Bethesda, MD.

NeuroInDx receives fourth NIH/NIMH SBIR Phase I award

lili — Fri, 18 Feb 2011 01:06:28 +0000

NeuroInDx receives NIH/NIMH SBIR Phase I award to develop CTAS-Live for live tissue microdissection and cell collection.

NIH SBIR Commercialization Assistance Program

lili — Tue, 05 Oct 2010 18:25:35 +0000

NeuroInDx is selected for NIH SBIR Commercialization Assistance Program by the Larta Insitute.

Society for Neuroscience’s 40th Annual Meeting – San Diego

lili — Thu, 16 Sep 2010 19:48:56 +0000

NeuroIndx presents its CTAS prototype at the Society for Neuroscience’s 40th Annual Meeting, San Diego, CA.

Kudo LC, Fields T, Vi N, Bragin A, Karsten SL. CTAS: A novel low-cost capillary-based cell and tissue acquisition system for a wide range of applications. Poster Presentation.

American Neurological Association’s 135th Annual Meeting in San Francisco, CA

lili — Wed, 15 Sep 2010 21:43:18 +0000

NeuroInDx presents its FAST-MD concept at American Neurological Association’s 135th Annual Meeting in San Francisco, CA.

Morales-Villagrán A, Morales-Rodríguez D, Medina-Ceja L, López-Pérez S, Vi N, Bragin A, Karsten SL and Kudo LC. High-throughput microarray-based microdialysis (FAST-MD) with parallel measurements of brain electrical activity. Poster presentation.

Dr. Karsten along with other panelists discusses the issues related with microdissection and cell specific transcriptome analyses at the Webinar organized by Alzheimer Research Forum.

Alzheimer Research Forum. Live Discussion: Microdissection and Microarrays: Analyzing Selective Cell Vulnerability.

NeuroInDx’s FAST-MD concept

lili — Wed, 15 Sep 2010 21:42:33 +0000

NeuroInDx’s FAST-MD concept is selected for the NIH SBIR Niche Assessment Program (NOT-OD-08-100). Foresight Science and Technology will perform Technology Niche Analyses (TNA™) to assess potential uses of FAST-MD technology and its advantages, competitors, market, price and a commercialization strategy.

NeuroInDx receives NIH/NCRR SBIR Phase II award

lili — Tue, 01 Jun 2010 22:05:54 +0000

NeuroInDx receives NIH/NCRR SBIR Phase II award to further develop and commercialize low cost cell and tissue acquisition system (CTAS).

Experimental Biology

lili — Mon, 26 Apr 2010 22:06:22 +0000

NeuroInDx presents its CTAS concept and latest results from the epilepsy project at the Experimental Biology meeting, April 24-28. Anaheim, CA.

Karsten SL, Vi N, Bragin A, Mazarati A, Kudo LC. Predicting epilepsy with peripheral blood transcriptome biomarkers during early latent period. Experimental Biology. Annual Meeting of the American Physiological Society. FASEB J. 2010 24:lb28. Poster Presentation.

Kudo LC, Fields T, Vi N, Bragi A, and Karsten SL. CTAS: a novel low-cost capillary-based cell and tissue acquisition system. Experimental Biology 2010. Annual Meeting of the American Physiological Society. FASEB J. 2010 24:lb452. Poster Presentation.

Epilepsy Pipeline Update

lili — Fri, 26 Feb 2010 22:07:57 +0000

Dr. Karsten presents results of epilepsy project at Epilepsy Pipeline Update Conference in San Francisco organized by Epilepsy Therapy Project.

Karsten SL. Peripheral blood transcriptome biomarkers for the identification of pre-epileptic patients.